Showing 6001-6010 of 20929 results for "".
- Transformative Role of Urine-Based Biomarkers in Early Prostate Cancer Detectionhttps://reachmd.com/news/transformative-role-of-urine-based-biomarkers-in-early-prostate-cancer-detection/2475558/Urologists face a clinical paradox: how to catch prostate malignancies early while sparing patients the pain and complications of invasive procedures. Recent data reveal how the
- RSV Vaccination 2025: Navigating CDC Updates and Addressing Health Disparitieshttps://reachmd.com/news/rsv-vaccination-2025-navigating-cdc-updates-and-addressing-health-disparities/2475559/Infectious disease specialists are adapting to the shifting landscape of RSV vaccination to effectively guide patient care, as recent updates from the CDC redefine age-based eligibility and emphasize addressing health disparities. Spec
- Digital Health Strategies and Their Role in Colorectal Cancer Screeninghttps://reachmd.com/news/digital-health-strategies-and-their-role-in-colorectal-cancer-screening/2475572/In the evolving landscape of oncology and digital health, the effectiveness of digital tools for colorectal cancer (CRC) screening significantly depends on the implementation strategies employed. Recent evidence from cluster randomized trials highlights the critical distinc
- Analysis Concludes No Single Preclinical Model Fully Mimics Human PsOhttps://reachmd.com/news/Analysis-Concludes-No-Single-Preclinical-Model-Fully-Mimics-Human-PsO/2475576/Despite extensive preclinical model development, no single system fully mimics human psoriatic disease, according to a new analysis published in Expert Opinion on Drug Discovery. Researchers on the study emphasized the importance of preclinical models that can reproduce disease-re
- Targeting HIV-1 Vpr: Disrupting Viral Replication for New Antiviral Strategieshttps://reachmd.com/news/targeting-hiv-1-vpr-disrupting-viral-replication-for-new-antiviral-strategies/2475569/As HIV-1 continues to challenge global health, new insights into the viral protein R (Vpr) reveal it as a pivotal influencer of replication in T cells and macrophages, posing both challenges and opportunities for treatment advancements. <
- Navigating Therapeutic Decisions in Hepatocellular Carcinoma: TACE vs. TAREhttps://reachmd.com/news/navigating-therapeutic-decisions-in-hepatocellular-carcinoma-tace-vs-tare/2475553/Therapeutic decisions in early and intermediate-stage hepatocellular carcinoma demand careful weighing of locoregional modalities whose survival outcomes can diverge significantly. For oncologists, choosing between transarterial chemoe
- Evolving Nutritional Strategies in Managing Gynecological Diseaseshttps://reachmd.com/news/evolving-nutritional-strategies-in-managing-gynecological-diseases/2475549/Emerging evidence has uncovered how targeted dietary modifications can reshape inflammatory and hormonal pathways in conditions like endometriosis and polycystic ovarian syndrome, opening a new frontier in women's health management. Cl
- Balancing PSMA Radioligand Therapy in Metastatic Prostate Cancer with Comorbid Leukopeniahttps://reachmd.com/news/balancing-psma-radioligand-therapy-in-metastatic-prostate-cancer-with-comorbid-leukopenia/2475550/Emerging PSMA radioligand therapy regimens are advancing care for metastatic prostate cancer, yet clinicians must navigate the narrow margin between potent tumor control and hematologic safety. Managing metastatic prostate cancer incre
- The Evolutionary Mechanics of Placenta Shape Modern Obstetricshttps://reachmd.com/news/the-evolutionary-mechanics-of-placenta-shape-modern-obstetrics/2475546/Evolutionary mechanisms within the placenta, such as the invasion of maternal spiral arteries by extravillous trophoblasts, continue to dictate modern gestations, shaping maternal-fetal dynamics and clinical outcomes in ways obstetricians are
- EMP1’s Role in Pancreatic Tumor Progression and Precision Oncologyhttps://reachmd.com/news/emp1s-role-in-pancreatic-tumor-progression-and-precision-oncology/2475547/EMP1’s unexpected influence on pancreatic tumor progression is forcing a rethink of current therapies and opening doors to precision oncology approaches. In the context of pancreatic cancer, where the